+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Kidney Function Tests Market By Product, By End Use, By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

  • PDF Icon

    Report

  • May 2021
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5331388
The North America Kidney Function Tests Market is expected to witness market growth of 6.9% CAGR during the forecast period (2021-2027).

Clearance tests are considered as the gold standard for observation and assessment of glomerular filtration rate. Inulin and creatinine tests are included in these products, which offer an essential addition to conventional diagnostic tests in order to generate accurate results. In addition to it, these make sure that there is the lowest variation in performance due to their optimum sensitivity and accuracy. The adoption of kidney function tests is set to increase due to the low cost and high availability of these products.

Due to the increasing prevalence of Chronic kidney disease around the world and the huge economic cost related to it, the disease has become a global public health concern. As per the National Institutes of Health (NIH), the worldwide occurrence of CKD is approximately 14%. Besides, the rates of CKD risk factors like hypertension, diabetes, and obesity are constantly increasing due to the changing lifestyle patterns. This has resulted in a massive demand for essential screening tests in patients with hypertension and diabetes for CKD, hence boosting the adoption rate of the product. According to the study conducted by the International Diabetes Federation, in 2019, approximately 463 million individuals had diabetes around the globe, which is expected to arrive at 700 million by 2045.

The US market dominated the North America Blood Tests Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $80 million by 2027. The Canada market is experiencing a CAGR of 8.3% during (2021 - 2027). Additionally, The Mexico market is expected to witness a CAGR of 7.3% during (2021 - 2027).

Based on Product, the market is segmented into Clearance Test, Blood Tests, Urine Tests, Dilution & Concentration Tests, and Others. Based on End Use, the market is segmented into Hospitals, Diagnostic Laboratories, Research Laboratories and Institutes and others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens AG, Randox Laboratories Limited, Quest Diagnostics, Incorporated, Laboratory Corporation of America holdings, Sysmex Corporation, ACON Laboratories, Inc., and Nova Biomedical Corporation.

Scope of the Study

Market Segments covered in the Report:

By Product
  • Clearance Test
  • Blood Tests
  • Urine Tests
  • Dilution & Concentration Tests,
  • Others

By End Use
  • Hospitals
  • Diagnostic Laboratories
  • Research Laboratories and Institutes
  • others

By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled
  • Abbott Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Siemens AG
  • Randox Laboratories Limited
  • Quest Diagnostics, Incorporated
  • Laboratory Corporation of America holdings
  • Sysmex Corporation
  • ACON Laboratories, Inc.
  • Nova Biomedical Corporation

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Kidney Function Tests Market, by Product
1.4.2 North America Kidney Function Tests Market, by End Use
1.4.3 North America Kidney Function Tests Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Kidney Function Tests Market - Global
Chapter 4. North America Kidney Function Tests Market by Product
4.1 North America Clearance Test Market by Country
4.2 North America Blood Tests Market by Country
4.3 North America Urine Tests Market by Country
4.4 North America Dilution & Concentration Tests Market by Country
4.5 North America Other Product Market by Country
Chapter 5. North America Kidney Function Tests Market by End-use
5.1 North America Hospitals Market by Country
5.2 North America Diagnostic Laboratories Market by Country
5.3 North America Research Laboratories and Institutes Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Kidney Function Tests Market by Country
6.1 US Kidney Function Tests Market
6.1.1 US Kidney Function Tests Market by Product
6.1.2 US Kidney Function Tests Market by End-use
6.2 Canada Kidney Function Tests Market
6.2.1 Canada Kidney Function Tests Market by Product
6.2.2 Canada Kidney Function Tests Market by End-use
6.3 Mexico Kidney Function Tests Market
6.3.1 Mexico Kidney Function Tests Market by Product
6.3.2 Mexico Kidney Function Tests Market by End-use
6.4 Rest of North America Kidney Function Tests Market
6.4.1 Rest of North America Kidney Function Tests Market by Product
6.4.2 Rest of North America Kidney Function Tests Market by End-use
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 Danaher Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 F. Hoffmann-La Roche Ltd.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Acquisition and Mergers:
7.4 Siemens AG
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.5 Randox Laboratories Limited
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Quest Diagnostics, Incorporated
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Recent strategies and developments:
7.6.3.1 Partnerships, Collaborations, and Agreements:
7.6.3.2 Acquisition and Mergers:
7.7 Laboratory Corporation of America Holdings
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Recent strategies and developments:
7.7.4.1 Partnerships, Collaborations, and Agreements:
7.7.4.2 Product Launches and Product Expansions:
7.8 Sysmex Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Product Launches and Product Expansions:
7.9 ACON Laboratories, Inc.
7.9.1 Company Overview
7.10. Nova Biomedical Corporation
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Product Launches and Product Expansions:
7.10.2.2 Approvals:

Companies Mentioned

  • Abbott Laboratories
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Siemens AG
  • Randox Laboratories Limited
  • Quest Diagnostics, Incorporated
  • Laboratory Corporation of America holdings
  • Sysmex Corporation
  • ACON Laboratories, Inc.
  • Nova Biomedical Corporation

Methodology

Loading
LOADING...